Characteristics and follow-up of postmarketing studies of conditionally authorized medicines in the EU-Reference-Cited by-同舟云学术

Characteristics and follow-up of postmarketing studies of conditionally authorized medicines in the EU

Published:2016-04-22 Issue:1 Volume:82 Page:213-226
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Hoekman Jarno¹²,Klamer Thea T.¹,Mantel-Teeuwisse Aukje K.¹,Leufkens Hubert G. M.¹³,De Bruin Marie L.¹³

Affiliation:

1. Division of Pharmacoepidemiology & Clinical Pharmacology; Utrecht Institute for Pharmaceutical Sciences, Utrecht University; Utrecht The Netherlands

2. Innovation Studies Group, Copernicus Institute for Sustainable Development; Utrecht University; Utrecht The Netherlands

3. Dutch Medicines Evaluation Board; Utrecht The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12940/fullpdf

Reference21 articles.

1. Number of patients studied prior to approval of new medicines: a database analysis;Duijnhoven;PLoS Med,2013

2. Evaluation of post-authorization safety studies in the first cohort of EU risk management plans at time of regulatory approval;Giezen;Drug Saf,2009

3. Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response;Eichler;Nat Rev Drug Discov,2011

4. Evolution of regulatory frameworks;Breckenridge;Nat Rev Drug Discov,2011

5. New horizons in pharmaceutical regulation;Breckenridge;Nat Rev Drug Discov,2012

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Analysis of Post‐Authorization Measures for Advanced Medicinal Products Authorized in the European Union and in the United States of America Between 2009 and 2023;Clinical Pharmacology & Therapeutics;2024-08-14

2. The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report;Clinical Pharmacology & Therapeutics;2024-04-28

3. Health policy and regulatory authorities: challenges of technology regulation in Public Health Emergencies;Ciência & Saúde Coletiva;2024

4. Política de saúde e Autoridades Reguladoras: desafios da regulação de tecnologias nas Emergências em Saúde Pública;Ciência & Saúde Coletiva;2024

5. A descriptive analysis of postmarketing requirement studies and clinical trials;Pharmacoepidemiology and Drug Safety;2023-11-23